Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
  1. 4 Open-market sale EVP and General Counsel sold 10,000 shares at $85.00 ($850,000)
  2. 4 Open-market sale President & CEO sold 30,000 shares at $82.63 ($2,478,900)
  3. 4 Open-market sale Director sold 5,000 shares at $86.57 ($432,850)
  4. 4 Open-market sale EVP and General Counsel sold 12,370 shares at an average $88.43 ($1,093,884)
  5. 4 Open-market sale CFO & Executive Vice President sold 14,378 shares at an average $88.40 ($1,271,073)
  6. 4 Open-market sale Director sold 34,750 shares at an average $85.37 ($2,966,736)
  7. 4 Open-market sale President & CEO sold 40,000 shares at $85.35 ($3,414,000)
  8. 4 Open-market sale SVP, Controller and PAO sold 2,638 shares at $91.00 ($240,058)
  9. 4 Open-market sale Director sold 6,181 shares at $90.00 ($556,290)
  10. 4 Shares withheld for taxes EVP & Chief Commercial Officer gave up 260 shares (to pay taxes)
  11. 4 Open-market sale Director sold 5,000 shares at $85.00 ($425,000)
  12. 4 Open-market sale SVP, Controller and PAO sold 2,611 shares at $81.00 ($211,491)
  13. 4 Grant or award Director acquired 2,550 shares (grant or award)
  14. 4 Grant or award Director acquired 2,550 shares (grant or award)
  15. 4 Grant or award Director acquired 2,550 shares (grant or award)
  16. 4 Grant or award Director acquired 2,550 shares (grant or award)
  17. 4 Grant or award Director acquired 2,550 shares (grant or award)
  18. 4 Grant or award Director acquired 2,550 shares (grant or award)
  19. 4 Grant or award Director acquired 2,550 shares (grant or award)
  20. 4 Grant or award Director acquired 2,550 shares (grant or award)

Page 13 of 32 · 627 filings